BCKDK and non-small cell lung carcinoma: High expression of BCKDK and certain malignant proliferation behaviors have been confirmed in colorectal cancer (Lei et al., 2020), breast cancer (Xu C. et al., 2023), and NSCLC (Xue et al., 2023).